Barkhof F - Search Results

1

Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance.

Barkhof F, van Walderveen M. Barkhof F, et al. Philos Trans R Soc Lond B Biol Sci. 1999 Oct 29;354(1390):1675-86. doi: 10.1098/rstb.1999.0511. Philos Trans R Soc Lond B Biol Sci. 1999. PMID: 10603619 Free PMC article. Review.

2

A correlative triad of gadolinium-DTPA MRI, EDSS, and CSF-MBP in relapsing multiple sclerosis patients treated with high-dose intravenous methylprednisolone.

Barkhof F, Frequin ST, Hommes OR, Lamers K, Scheltens P, van Geel WJ, Valk J. Barkhof F, et al. Neurology. 1992 Jan;42(1):63-7. doi: 10.1212/wnl.42.1.63. Neurology. 1992. PMID: 1370864

3

Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity.

Barkhof F, Scheltens P, Frequin ST, Nauta JJ, Tas MW, Valk J, Hommes OR. Barkhof F, et al. AJR Am J Roentgenol. 1992 Nov;159(5):1041-7. doi: 10.2214/ajr.159.5.1414773. AJR Am J Roentgenol. 1992. PMID: 1414773

4

The effects of high-dose methylprednisolone on gadolinium-enhanced magnetic resonance imaging and cerebrospinal fluid measurements in multiple sclerosis.

Frequin ST, Barkhof F, Lamers KJ, Hommes OR. Frequin ST, et al. Among authors: barkhof f. J Neuroimmunol. 1992 Oct;40(2-3):265-72. doi: 10.1016/0165-5728(92)90142-8. J Neuroimmunol. 1992. PMID: 1430156 Review.

5

White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity.

Scheltens P, Barkhof F, Valk J, Algra PR, van der Hoop RG, Nauta J, Wolters EC. Scheltens P, et al. Among authors: barkhof f. Brain. 1992 Jun;115 ( Pt 3):735-48. doi: 10.1093/brain/115.3.735. Brain. 1992. PMID: 1628199

6

Gadopentetate dimeglumine enhancement of multiple sclerosis lesions on long TR spin-echo images at 0.6 T.

Barkhof F, Valk J, Hommes OR, Scheltens P, Nauta JJ. Barkhof F, et al. AJNR Am J Neuroradiol. 1992 Jul-Aug;13(4):1257-9. AJNR Am J Neuroradiol. 1992. PMID: 1636547 Free PMC article.

7

Quantitative MRI changes in gadolinium-DTPA enhancement after high-dose intravenous methylprednisolone in multiple sclerosis.

Barkhof F, Hommes OR, Scheltens P, Valk J. Barkhof F, et al. Neurology. 1991 Aug;41(8):1219-22. doi: 10.1212/wnl.41.8.1219. Neurology. 1991. PMID: 1866009

8

Partially saturated fluid attenuated inversion recovery (FLAIR) sequences in multiple sclerosis: comparison with fully relaxed FLAIR and conventional spin-echo.

Baratti C, Barkhof F, Hoogenraad F, Valk J. Baratti C, et al. Among authors: barkhof f. Magn Reson Imaging. 1995;13(4):513-21. doi: 10.1016/0730-725x(95)00009-6. Magn Reson Imaging. 1995. PMID: 7674846

9

Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images.

van Walderveen MA, Barkhof F, Hommes OR, Polman CH, Tobi H, Frequin ST, Valk J. van Walderveen MA, et al. Among authors: barkhof f. Neurology. 1995 Sep;45(9):1684-90. doi: 10.1212/wnl.45.9.1684. Neurology. 1995. PMID: 7675227

10

Multiple sclerosis therapy. A practical guide.

van Oosten BW, Truyen L, Barkhof F, Polman CH. van Oosten BW, et al. Among authors: barkhof f. Drugs. 1995 Feb;49(2):200-12. doi: 10.2165/00003495-199549020-00005. Drugs. 1995. PMID: 7729328 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,519 results

Search Page

Filters